Publications by authors named "Christopher D Benjamin"

Claim this Profile
S
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.
Jinesh S Gheeya, Qing-Rong Chen, Christopher D Benjamin, Adam T Cheuk, Patricia Tsang

Cancer Biol Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.
Janine L Ferrant, Christopher D Benjamin, Anne H Cutler, Susan L Kalled, Yen-Ming Hsu

Int Immunol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
John Reynolds, Sarah B Khan, Andrew R Allen, Christopher D Benjamin, Charles D Pusey

Kidney Int· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
Adam S R Bartlett, John L McCall, Rohan Ameratunga, Brian Howden, Ravi Ramadas, Christopher D Benjamin

J Surg Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation.
Fabien Sebille, Sophie Brouard, Thomas Petzold, Nicolas Degauque, Marina Guillet, Christopher D Benjamin

Transplantation· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors.
Robert A Barrington, Olga Pozdnyakova, Mohammad R Zafari, Christopher D Benjamin, Michael C Carroll

J Exp Med· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies.
Janine L Ferrant, Cheryl A Wilson, Christopher D Benjamin, Donna M Hess, Yen-Ming Hsu

Mol Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes.
Rhonda Larkin, Christopher D Benjamin, Yen-Ming Hsu, Qing Li, Lynn Zukowski

Infect Immun· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Xueli Yuan, Victor M Dong, Ana J Coito, Ana-Maria Waaga, Alan D Salama, Christopher D Benjamin

Transplantation· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
Adam S Bartlett, John L McCall, Rohan Ameratunga, Brian Howden, Mee-Ling Yeong, Christopher D Benjamin

Liver Transpl· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual role for TWEAK in angiogenic regulation.
Aniela Jakubowski, Beth Browning, Matvey Lukashev, Irene Sizing, Jeffrey S Thompson, Christopher D Benjamin

J Cell Sci· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis